FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM
Total 13F shares
11,393,348
Share change
+462,821
Total reported value
$177,169,357
Price per share
$15.55
Number of holders
61
Value change
+$3,009,037
Number of buys
38
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q2 2014

As of 30 Jun 2014, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,393,348 shares. The largest 10 holders included WELLINGTON MANAGEMENT CO LLP, BVF INC/IL, ORBIMED ADVISORS LLC, TPG Group Holdings (SBS) Advisors, Inc., EVENTIDE ASSET MANAGEMENT, LLC, QVT Financial LP, GOLDMAN SACHS GROUP INC, PUTNAM INVESTMENTS LLC, FRANKLIN RESOURCES INC, and BlackRock Fund Advisors. This page lists 61 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.